Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis

Gastroenterology and Hepatology from Bed to Bench

Volumn 9, Issue 4, 2016, Pages 325-330

  Ganji, Leila ^a   Alebouyeh, Masoud ^b   Shirazi, Mohammad Hassan ^a   Eshraghi, Seyed Saeed ^a   Mirshafiey, Abbas ^a   Daryani, Naser Ebrahimi ^c   Zali, Mohammad Reza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dysbiosis; Gastroenteritis; Irritable bowel syndrome

Indexed keywords

ADULT; ARTICLE; CITROBACTER FREUNDII; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; DYSBIOSIS; EPITHELIUM CELL; ERYTHROCYTE COUNT; ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; GASTROENTERITIS; HUMAN; IRRITABLE COLON; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PEPTOCLOSTRIDIUM DIFFICILE;

EID: 85009486456     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet J, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11: 2574-84.
2. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237-42.
3. Müller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001; 64: 200-04.
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
5. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42: 41-7.
6. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
7. Othman M, Agüero R, Lin HC. Alterations in intestinal microbial flora and human disease. Curr Opin Gastroenterol 2008; 24: 11-6.
8. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-73.
9. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22: 512-e115.
10. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
11. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrheapredominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24: 521-e248.
12. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802-805.
13. DiBaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006; 4: 11-20.
14. Collins BS, Lin HC. Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation. Dig Dis Sci 2010; 55: 124-30.
15. Faber SM. Treatment of abnormal gut flora improves symptoms in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2533.
16. Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome---a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005; 43: 213-22.
17. Jeffery IB, O'Toole PW, +ûhman L, Claesson MJ, Deane J, Quigley EM, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006.
18. Jeffery IB, O'Toole PW, öhman L, Claesson MJ, Deane J, Quigley EM, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
19. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008; 57: 1605-15.